Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.73 USD | -0.92% | -1.15% | -20.17% |
05-02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
05-01 | Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75 | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GILEAD SCIENCES, INC. | Other Pharmaceuticals | -1.07% | -1.15% | -20.17% | -18.60% | -3.66% | 81.46B |
- Stock Market
- Equities
- GILD Stock
- Charts Gilead Sciences, Inc.
- Relative Strength Chart